Advisor Group Holdings, Inc. Assembly Biosciences, Inc. Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.8 - $1.74 $14 - $31	-18 Reduced 3.47%	500 $0
Q1 2022 May 04, 2022	BUY	$1.46 - $2.45 $728 - $1,222	499 Added 2626.32%	518 $1,000
Q3 2021 Nov 05, 2021	SELL	$3.14 - $3.9 $119 - $148	-38 Reduced 66.67%	19 $0
Q2 2021 Aug 02, 2021	BUY	$3.8 - $4.56 $216 - $259	57 New	57 $0

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.